| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1083043
[patent_doc_number] => 06833383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-21
[patent_title] => 'Methods for treating patients suffering from drug dependencies which lead to plasma melatonin deficiencies'
[patent_app_type] => B2
[patent_app_number] => 10/144037
[patent_app_country] => US
[patent_app_date] => 2002-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6361
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/833/06833383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144037 | Methods for treating patients suffering from drug dependencies which lead to plasma melatonin deficiencies | May 13, 2002 | Issued |
| 10/019111 | Use of 1,2,4-triazolo' 1,5-a! pyrimidines | May 8, 2002 | Abandoned |
Array
(
[id] => 6440437
[patent_doc_number] => 20020128314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Methods and compositions for treating male erectile dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/139203
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7852
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139203
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139203 | Methods and compositions for treating male erectile dysfunction | May 2, 2002 | Issued |
Array
(
[id] => 6554382
[patent_doc_number] => 20020164323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Pharmaceutical preparation for the treatment of inflammatory processes'
[patent_app_type] => new
[patent_app_number] => 10/127572
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1396
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127572 | Pharmaceutical preparation for the treatment of inflammatory processes | Apr 22, 2002 | Issued |
| 10/125407 | METHOD OF TIZANIDINE THERAPY | Apr 18, 2002 | Abandoned |
Array
(
[id] => 1080686
[patent_doc_number] => 06835722
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'Pharmaceutical compositions and preparations for treatment of metabolic bone disease'
[patent_app_type] => B1
[patent_app_number] => 10/111270
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 11772
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835722.pdf
[firstpage_image] =>[orig_patent_app_number] => 10111270
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/111270 | Pharmaceutical compositions and preparations for treatment of metabolic bone disease | Apr 18, 2002 | Issued |
Array
(
[id] => 6756366
[patent_doc_number] => 20030004143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Use of NSAIDs for prevention and treatment of cellular abnormalities of the female reproductive tract'
[patent_app_type] => new
[patent_app_number] => 10/125218
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4199
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125218 | Use of NSAIDs for prevention and treatment of cellular abnormalities of the female reproductive tract | Apr 17, 2002 | Abandoned |
Array
(
[id] => 6178188
[patent_doc_number] => 20020156121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Methods for treating patients suffering from drug dependencies which leads to plasma melatonin deficiencies'
[patent_app_type] => new
[patent_app_number] => 10/117054
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6298
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117054 | Methods for treating patients suffering from drug dependencies which leads to plasma melatonin deficiencies | Apr 7, 2002 | Abandoned |
Array
(
[id] => 6658349
[patent_doc_number] => 20030078299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Anti-cancer nitro- and thia-fatty acids'
[patent_app_type] => new
[patent_app_number] => 10/100274
[patent_app_country] => US
[patent_app_date] => 2002-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20388
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10100274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/100274 | Anti-cancer nitro- and thia-fatty acids | Mar 17, 2002 | Abandoned |
Array
(
[id] => 5845369
[patent_doc_number] => 20020132815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Anti-hypertensive composition and methods of treatment'
[patent_app_type] => new
[patent_app_number] => 10/091395
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1884
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132815.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091395 | Anti-hypertensive composition and methods of treatment | Mar 6, 2002 | Issued |
Array
(
[id] => 6818211
[patent_doc_number] => 20030069169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders'
[patent_app_type] => new
[patent_app_number] => 10/090258
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21906
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090258 | Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders | Mar 3, 2002 | Abandoned |
Array
(
[id] => 1236152
[patent_doc_number] => 06689816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-10
[patent_title] => 'Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders'
[patent_app_type] => B2
[patent_app_number] => 10/087357
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13030
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/689/06689816.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087357 | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders | Feb 28, 2002 | Issued |
Array
(
[id] => 6569296
[patent_doc_number] => 20020165257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Epothilone derivatives for the treatment of refractory tumors'
[patent_app_type] => new
[patent_app_number] => 10/071988
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8221
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165257.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071988 | Epothilone derivatives for the treatment of refractory tumors | Feb 7, 2002 | Issued |
| 10/049348 | Calcilytic compounds | Jan 29, 2002 | Abandoned |
| 09/937752 | Estrogen receptors-beta antagonism and bone diseases | Jan 23, 2002 | Abandoned |
Array
(
[id] => 6674899
[patent_doc_number] => 20030060502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Treatment of diabetes with statins (HMG-COa reductase inhibitors)'
[patent_app_type] => new
[patent_app_number] => 10/056645
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 17250
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056645
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056645 | Treatment of diabetes with statins (HMG-COa reductase inhibitors) | Jan 22, 2002 | Abandoned |
Array
(
[id] => 5786275
[patent_doc_number] => 20020159974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Treatment of multiple sclerosis with statins (HMG-CoA reductase inhibitors)'
[patent_app_type] => new
[patent_app_number] => 10/056608
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16857
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20020159974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056608 | Treatment of multiple sclerosis with statins (HMG-CoA reductase inhibitors) | Jan 22, 2002 | Abandoned |
Array
(
[id] => 6783571
[patent_doc_number] => 20030065019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Treatment of rheumatoid arthritis with statins (HMG-CoA reductase inhibitors)'
[patent_app_type] => new
[patent_app_number] => 10/056646
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16849
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20030065019.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056646 | Treatment of rheumatoid arthritis with statins (HMG-CoA reductase inhibitors) | Jan 22, 2002 | Abandoned |
Array
(
[id] => 6674898
[patent_doc_number] => 20030060501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Facilitating tissue grafts with statins (HMG-COa reductase inhibitors)'
[patent_app_type] => new
[patent_app_number] => 10/056606
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16850
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056606 | Facilitating tissue grafts with statins (HMG-COa reductase inhibitors) | Jan 22, 2002 | Abandoned |
Array
(
[id] => 6674897
[patent_doc_number] => 20030060500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Facilitating organ transplantation with statins (HMG-CoA reductase inhibitors)'
[patent_app_type] => new
[patent_app_number] => 10/056133
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16867
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056133 | Facilitating organ transplantation with statins (HMG-CoA reductase inhibitors) | Jan 22, 2002 | Abandoned |
